Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Premature clinical trials
5 of 5 indexed Premature trials are currently recruiting.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 5 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Premature: 5 US clinical trials tracked, 5 recruiting.
Premature is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. The most active sponsor is Hackensack Meridian Health, running 1 of these trials.
Enrollment posture brief
Registry condition premature
OPEN 5 | RECR 100% | LATE 0 | EARLY 0 | RANK #3391 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)
Premature lists 5 open slots (100% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Premature on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Premature is recruiting above its size-band peers.
5 of 5 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Premature research.
Hackensack Meridian Health accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.
-
Typical Premature enrolment sits around 152 participants.
Median target enrolment is 152 among the 5 trials that report a genuine target (sentinel values excluded). 1 of those (20%) plan for fewer than 100 participants.
-
Premature splits between interventional and observational designs.
3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Metabolic Mechanisms Induced by Enteral DHA and ARA Supplementation in Preterm Infants
The University of Texas Health Science Center at San Antonio
NCT05380401
Predictive Value of Lung Ultrasound for Respiratory Decompensation in Late Preterm Neonates
Hackensack Meridian Health
NCT07216053
Early DHA/ARA Supplementation in Growth-restricted Very Preterm Infants: A Randomized Clinical Trial
University of Alabama at Birmingham
NCT06207071
Growing Little PEAPODS Study
University of Wisconsin, Madison
NCT06226051
Baby ABS (Abdominal Binder Study)
University of Minnesota
NCT07049900
Phase Distribution
Phase data not available
Top Sponsors
Named interventions
Most-linked intervention names on Premature records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Premature trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Premature page
5 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 5 Premature trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Hackensack Meridian Health sponsors the most Premature trials on record, review their full trial history before evaluating a specific study. See Hackensack Meridian Health's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Premature condition card totals 5 registered trials; most-linked intervention PEAPOD Infant Body Composition measuring device; top US site state Wisconsin. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.